Consensus MedPlus Health Services Limited

Equities

MEDPLUS

INE804L01022

Market Closed - NSE India S.E. Other stock markets 07:43:52 2024-05-22 EDT			5-day change	1st Jan Change
698 ^INR	-1.10%		-0.89%	-7.02%

05-05	Optival Health Solutions Private Limited Received Order for Temporarily Suspending the Operations of Store situated at Prakash Nagar Kurnool District Andra Pradesh, C.B Pura Road and MB Road Kolar, Karnataka for seven days each store	CI
03-25	Medplus Health Services Arm Gets Order for Temporary Suspension of Operations	MT

Evolution of the average Target Price on MedPlus Health Services Limited

Price target over the last 5 years

History of analyst recommendation changes

3edd585b9da7c439a.MKIIKY0CDNAaw3G0VnLembADkSlo3IKm7qgC7lyPUWI.XvZOQd9VaY9Z9xP9I0a9-8A7_FM9rOjEvfxw2mvbJFZn20tw_TFH4X2NMA~b3b53d0a15ef82487e26e3bb56ef12c3

Analyst Recommendations on MedPlus Health Services Limited

Nomura Adjusts Medplus Health Services' Price Target to INR982 From INR974, Keeps at Buy	02-09	MT
India's Nifty set to open higher tracking Asian peers	12-21	RE
Nomura Adjusts Medplus Health Services' Price Target to INR974 From INR952, Keeps at Buy	12-11	MT
Nomura Adjusts Medplus Health Services' Price Target to INR952 From INR885, Keeps at Buy	23-05-29	MT
Nomura Adjusts Medplus Health Services' Price Target to INR885 From INR928, Keeps at Buy	23-02-10	MT
Nomura Adjusts Medplus Health Services' Price Target to 928 Indian Rupees From 925 Rupees, Keeps at Buy	22-11-15	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

705.8 INR

Average target price

878.4 INR

Spread / Average Target

+24.45%

High Price Target

1,045 INR

Spread / Highest target

+48.06%

Low Price Target

770 INR

Spread / Lowest Target

+9.10%

Consensus detail

Consensus revision (last 18 months)

Analysts covering MedPlus Health Services Limited

Nomura

Ratings for MedPlus Health Services Limited

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar